Artiva Biotherapeutics Inc. (ARTV)
Market Closed
12 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
8. 54
+0.54
+6.75%
$
211.08M Market Cap
- P/E Ratio
- Div Yield
1.43M Volume
- Eps
$ 8
Previous Close Investors:
Want to track ARTV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ARTV Earnings Reports FAQ
What is the earnings per share (EPS) for ARTV?
EPS data for ARTV is currently not available, as Artiva Biotherapeutics Inc has not reported recent earnings.
What is the company's earnings growth rate?
Artiva Biotherapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Artiva Biotherapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Artiva Biotherapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ARTV at this time, as Artiva Biotherapeutics Inc has no recent EPS data to calculate it.
